摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-hydrazino-2,5-dimethyl-pyrazine | 19848-58-9

中文名称
——
中文别名
——
英文名称
3-hydrazino-2,5-dimethyl-pyrazine
英文别名
3-hydrazinyl-2,5-dimethylPyrazine;(3,6-dimethylpyrazin-2-yl)hydrazine
3-hydrazino-2,5-dimethyl-pyrazine化学式
CAS
19848-58-9
化学式
C6H10N4
mdl
——
分子量
138.172
InChiKey
JIYZRGBJTOMYRD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    121 °C
  • 沸点:
    256.0±23.0 °C(Predicted)
  • 密度:
    1.26±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    63.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-hydrazino-2,5-dimethyl-pyrazine盐酸 、 sodium hydride 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 5.5h, 生成 1-benzyl-1-(2,5-dimethylpyrazin-6-yl)hydrazine
    参考文献:
    名称:
    Crabb, Derek L.; Main, David A.; Morley, John O., Journal of the Chemical Society. Perkin transactions II, 1997, # 1, p. 49 - 58
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    发现了有效的和选择性的二肽基肽酶IV抑制剂,该抑制剂衍生自带有取代的三唑并哌嗪的β-氨基酰胺。
    摘要:
    通过围绕三唑并哌嗪部分的广泛结构-活性关系(SAR)研究,已发现一系列带有三唑并哌嗪的β-氨基酰胺为有效,选择性和口服活性的二肽基肽酶IV(DPP-4)抑制剂。在这些化合物中,对DPP-4具有优异的体外效力(IC50 = 4.3 nM),对其他酶的选择性高以及良好的药代动力学特征的化合物34b在瘦小鼠的口服葡萄糖耐量试验(OGTT)中显示出明显的体内功效。基于这些性质,化合物34b已被详细剖析。对三唑并哌嗪的进一步改良导致发现了一系列对DPP-4(42b-49b)具有亚纳摩尔活性的极其有效的化合物,即4-氟苄基取代的化合物46b,以其优越的效力而著称(IC50 = 0。18 nM)。与DPP-4酶复合的化合物34b和46b的X射线晶体结构测定表明,就DPP-4抑制而言,三唑并哌嗪在8位的(R)-立体化学优于(S)。
    DOI:
    10.1021/jm070330v
点击查看最新优质反应信息

文献信息

  • Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
    申请人:Kim Dooseop
    公开号:US20060014953A1
    公开(公告)日:2006-01-19
    The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
    本发明涉及抑制二肽基肽酶-IV酶(“DP-IV抑制剂”)的化合物,该化合物在治疗或预防二肽基肽酶-IV酶参与的疾病中,如糖尿病和特别是2型糖尿病中有用。本发明还涉及含有这些化合物的药物组合物以及使用这些化合物和组合物在预防或治疗二肽基肽酶-IV酶参与的这些疾病中的应用。
  • Metal-containing azo compound and optical recording media
    申请人:Matsushita Electric Industrial Co., Ltd.
    公开号:US06551682B1
    公开(公告)日:2003-04-22
    There is provided a metal-containing azo compound suitably used for an recording layer of an optical medium, which is represented by at least one of the following general formulae: wherein M(II) is a bivalent metal, X1 and X2 are each a residue that forms a monocyclic or polycyclic aromatic ring, Y1 and Y2 are each a residue that forms a nitrogen-containing aromatic heterocycle, and one residue is different from the other in at least one of a combination of X1 and X2, and a combination of Y1 and Y2; and there is also provided an optical recording medium of which recording layer comprises said metal-containing azo compound.
    提供一种含金属的偶氮化合物,适用于光学介质的记录层,该化合物由以下至少一种普通式表示:其中M(II)是二价金属,X1和X2分别是形成单环或多环芳香环的残基,Y1和Y2分别是形成含氮芳香杂环的残基,其中一个残基在X1和X2的组合以及Y1和Y2的组合中与另一个残基不同;还提供一种光学记录介质,其记录层包含上述含金属的偶氮化合物。
  • Beta-amino heterocyclic dipeptidyl peptidase inhibitors for diabetes
    申请人:Merck & Co., Inc.
    公开号:US07390809B2
    公开(公告)日:2008-06-24
    The present invention is directed to compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved
    本发明涉及结构式(I)的化合物,其为二肽基肽酶-IV酶(“DP-IV抑制剂”)的抑制剂,并且在治疗或预防二肽基肽酶-IV酶涉及的疾病,如糖尿病,特别是2型糖尿病中有用。本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗二肽基肽酶-IV酶涉及的疾病中的使用。
  • OPTICAL RECORDING MEDIUM AND METHOD OF PRODUCING THE SAME
    申请人:MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
    公开号:EP0995612A1
    公开(公告)日:2000-04-26
    A write-once optical recording medium having on a substrate a recording layer on which information can be written and/or read out therefrom with a laser beam, where a proper tracking error signals is ensured over the whole substrate of the medium. The medium is adaptable to high information recording density. This medium is produced by forming a recording layer by vacuum depositing on the substrate a recording layer-constituting material containing a metal-containing azo compound having a weight-loss starting temperature or a decomposition temperature ranging from 300 to 500 °C.
    一种一次性写入光学记录介质,其基板上有一个记录层,可以用激光束在上面写入和/或读出信息,在介质的整个基板上确保有适当的跟踪误差信号。这种介质可适应高信息记录密度。这种介质是通过在基底上真空沉积含有含金属偶氮化合物的记录层构成材料来形成记录层的,这种材料的失重起始温度或分解温度在 300 ℃ 至 500 ℃ 之间。
  • WO2007/27842
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多